SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB:
SEC Accession No. 0001213900-22-027566
Filing Date
2022-05-17
Accepted
2022-05-17 13:19:52
Documents
1
Period of Report
2022-03-31
Effectiveness Date
2022-05-17

Document Format Files

Seq Description Document Type Size
1 NOTIFICATION OF LATE FILING ea160170-nt10q_rasnatherap.htm NT 10-Q 26031
  Complete submission text file 0001213900-22-027566.txt   27186
Mailing Address 420 LEXINGTON AVENUE SUITE 2525 NEW YORK NY 10170
Business Address 420 LEXINGTON AVENUE SUITE 2525 NEW YORK NY 10170 646-396-4087
Rasna Therapeutics Inc. (Filer) CIK: 0001582249 (see all company filings)

IRS No.: 392080103 | State of Incorp.: NV | Fiscal Year End: 0930
Type: NT 10-Q | Act: 34 | File No.: 333-191083 | Film No.: 22933470
SIC: 2834 Pharmaceutical Preparations